Amynon's business concept is the result of extensive scientific research of the team in the field of HPV-induced diseases and the exploration of cellular processes during tumour development.
Actual result are the development of the product line 'PapTec', diagnostic assays, that bases on a mixture of polyclonal antibodies, and allow an early, reliable and accurate diagnosis of cervical cancer in PapSmear, LBC, body liquids, cell lysates, and biopsies.
Want to reach amynon? Find out how partnering with amynon can help promote your business.
New diagnostics for the early detection of cervical cancer